Hyloris Pharmaceuticals

About:

Hyloris Pharmaceuticals is an innovative specialty pharmaceutical company.

Top Investors: Meusinvest (Noshaq), Walloon, Saffelberg Investments, Scorpiaux

Description:

Hyloris Pharmaceuticals is an innovative specialty pharmaceutical company focused on adding value to the healthcare system by reformulating well-known pharmaceuticals. Hyloris Pharmaceuticals develop innovative proprietary products that offer significant advantages compared to currently available alternatives.

Total Funding Amount:

31M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Liège, Liege, Belgium

Founded Date:

2013-01-01

Founders:

Stijn Van Rompay, Thomas Jacobsen

Number of Employees:

11-50

Last Funding Date:

2023-06-23

IPO Status:

Public

Industries: